Phase 1/2 Study of Carfilzomib, Pomalidomide, and Dexamethasone with and Without Daratumumab in Relapsed Multiple Myeloma
Blood Advances（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined